RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR
RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR
Recruiting · NCT06571825 · Registry updated 2024-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 4 | 2024-08-26 | NCT06571825 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| He Huang | 12 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Zhejiang University School of Medicine | Hangzhou | China | 4 |